PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2003 March; 4(1): 1–5.
Published online 2003 January 9. doi:  10.1208/pt040101
PMCID: PMC2750297

Synergistic effect of PEG-400 and cyclodextrin to enhance solubility of progesterone

Conclusion

PEG-400, polysorbate 80, and 2 CDs (Trappsol HPB and Captisol) were used in an attempt to improve the aqueous solubility of a model hydrophobic drug, progesterone. The aqueous solubility of progesterone improved significantly from 0.007 mg/mL by the addition of PEG-400, CDs, and polysorbate 80. In systems containing various amounts of PEG-400 and 3% Trappsol HPB in water (% wt/wt), the theoretical solubility was calculated by adding the solubilities in the individual systems. The observed solubility values were up to 96% higher than the theoretical values. The effect of synergism was significant in 5% to 50% PEG-400/water systems containing Trappsol HPB. Systems containing Captisol did not show such synergistic effects. In general, the addition of polysorbate 80 to the PEG-400/water systems containing CDs affected synergism negatively.

Keywords: cosolvent, cyclodextrins, PEG-400, progesterone, solubilization, synergism

Full Text

The Full Text of this article is available as a PDF (234K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Loftsson T, Brewster ME. Pharmaceutical application of cyclodextrin: drug solubilization and stabilization. J Pharm Sci. 1996;85:1017–1025. doi: 10.1021/js950534b. [PubMed] [Cross Ref]
2. Wulff M, Alden M. Solid state studies of drug—cyclodextrin inclusion complexes in PEG 6000 prepared by a new method. Eur J Pharm. 1999;8:269–281. doi: 10.1016/S0928-0987(99)00020-2. [PubMed] [Cross Ref]
3. Harada A. Preparation and structures of supramolecules between cyclodextrins and polymers. Coordin Chem Rev. 1996;148:115–133. doi: 10.1016/0010-8545(95)01157-9. [Cross Ref]
4. Loftsson T, Olafsdottir BJ, Fridriksdottir H, Jonsdottir S. Cyclodextrin complexations of NSAIDs: physicochemical characteristics. Eur J Pharm Sci. 1993;1:95–101. doi: 10.1016/0928-0987(93)90023-4. [Cross Ref]
5. Savolainen J, Jarvinen K, Taipale H, Jarho P, Loftsson T, Jarvinen T. Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid dosage forms. Pharm Res. 1998;15:1696–1701. doi: 10.1023/A:1011900527021. [PubMed] [Cross Ref]
6. Loftsson T, Petersen DS. Cyclodextrin solubilization of ETH-615, a zwitterionic drug. Drug Dev Ind Pharm. 1998;24:365–370. doi: 10.3109/03639049809085632. [PubMed] [Cross Ref]
7. Loftsson T, Gudmundsdottir H, Sigurjonsdottir JF, et al. Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int J Pharm. 2001;212:29–40. doi: 10.1016/S0378-5173(00)00580-9. [PubMed] [Cross Ref]
8. Zung JB. Influence of alcohol addition on the γ-CD:pyrene complex. J Phys Chem. 1991;95:6701–6709. doi: 10.1021/j100170a059. [Cross Ref]
9. Pitha J, Hoshino T. Effect of ethanol on formation of inclusion complexes of hydroxypropylcyclodextrins with testosterone or with methyl orange. Int J Pharm. 1992;80:243–251. doi: 10.1016/0378-5173(92)90281-6. [Cross Ref]
10. Faucci MT, Mura P. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified β-cyclodextrins. Drug Dev Ind Pharm. 2001;27:909–917. [PubMed]
11. Li P, Zhao L, Yalkowsky SH. Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs. J Pharm Sci. 1999;88:1107–1111. doi: 10.1021/js990159d. [PubMed] [Cross Ref]
12. Martin A. Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences. Philadelphia, PA: Lea and Febiger; 1993. pp. 223–223.
13. Millard JW, Alvarex-Nunez FA, Yalkowsky SH. Solubilization by cosolvents—establishing useful constants for the log-linear model. Int J Pharm. 2002;245:153–166. doi: 10.1016/S0378-5173(02)00334-4. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists